JTelmiplus Tablet 40/12.5 mg (Telmisartan, Hydrochlorothiazide)

Adult dose

Patients who do not achieve adequate blood pressure control with sole Telmisartan can take this medication once daily with or without food. The Telmisartan/Hydrochlorothiazide combination 40/12.5 mg can be administered to patients whose blood pressure is not adequately controlled with 40 mg of Telmisartan alone. The Telmisartan/Hydrochlorothiazide combination 80/12.5 mg can be administered to patients whose blood pressure is not adequately controlled with 80 mg of Telmisartan.

Child dose

The safety and efficacy of this medication have not been established for children under 18 years of age.

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. Patients who are allergic to the active ingredient or additives of this medication, or who have allergies to certain sulfonamide-class drugs, should not take this medication. Patients with severe liver or kidney dysfunction, those with obstructive biliary diseases, pregnant women in the second and third trimesters, and nursing mothers should not take this medication. Elderly patients, those with hyperkalemia, liver dysfunction, heart valve diseases, and renal vascular hypertension should use this medication with caution, and blood pressure should be monitored to avoid hypotension. The Hydrochlorothiazide component can make the skin sensitive to sunlight and increase the risk of skin cancer, so sun exposure should be avoided while taking this medication, and any skin abnormalities should be reported to a doctor immediately. While taking this medication, symptoms such as dizziness, drowsiness, and blurred vision may occur, so caution should be exercised when driving or operating machinery. Electrolyte imbalances may occur, so regular blood tests should be performed to monitor potassium, sodium, and magnesium levels. There may be interactions when taken with other antihypertensives, diuretics, lithium, certain antiarrhythmics, and non-steroidal anti-inflammatory drugs, so notify your doctor or pharmacist. In case of overdose, hypotension, electrolyte abnormalities, and dehydration may occur, so the dosage must be strictly adhered to, and if any unusual symptoms arise, medical consultation should be sought immediately. Safety and efficacy in children have not been established, so its use is not recommended. This medication should be stored out of reach of children, and it is advisable not to transfer it to another container.

Serious side effects

Urticaria, severe swelling (edema), angioedema, chest tightness, difficulty breathing, respiratory distress, pneumonia, pulmonary edema, exacerbation or activation of systemic lupus erythematosus, angioedema (with fatal outcomes), severe rash with high fever, blisters, skin peeling, painful mucous membranes of mouth/eyes, yellowing of skin or eyes (jaundice), abnormal liver function/liver dysfunction, hepatocellular jaundice, cholestatic jaundice, sudden and severe complications

Mild side effects

• Hypokalemia
• hyperuricemia
• hyponatremia
• anxiety
• depression
• dizziness
• fainting
• sensory abnormalities
• insomnia
• sleep disturbances

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature. This way, the effectiveness of the medication can be safely maintained.

Appearance

White or almost white, biconvex, round tablet

Package unit

10 tablets/blister[X3], 100 tablets/bottle